Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial

Günal A. İ., Özalp G., Yoldaş T., GÜNAL S., Kırcıman E., Çeliker H.

NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.19, sa.12, ss.3137-3139, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 12
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1093/ndt/gfh496
  • Dergi Adı: NEPHROLOGY DIALYSIS TRANSPLANTATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3137-3139
  • Erciyes Üniversitesi Adresli: Hayır

Özet

Background. Uraemic pruritus is a common and distressing symptom in patients on haemodialysis for chronic renal failure. Gabapentin is an anticonvulsant that alleviates neuropathic pain. We conducted a double-blind. placebo-controlled, crossover study to assess its effectiveness against renal itch.